Our Work

Our Qual team has conducted thousands of interviews with patients and medical professionals. We map patient journeys, test and refine diabetes devices in development, assess communication effectiveness and uncover prescribing drivers and barriers.

People with Type 1 diabetes (PWT1) in Europe (EU) and the United States (USA) generally have similar access to diabetes technologies. So how do their health outcomes compare? dQ&A’s work shows that even with similar treatment plans, differing regional factors influencing diabetes management — such as obesity levels and the cost and accessibility of healthcare — potentially affect patient wellness.

The latest data in our current survey highlights geographical differences in the comorbidities experienced by people with diabetes along with satisfaction with their glucose control.